How Does Prostate Cancer Metastasize? Studying the Role of Secreted Packages (Exosomes) From Fat Tissue in Lean and Obese Patients
NCT04167722 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-09-22
Summary
The investigators will be collecting prostate and fat tissue from participants undergoing radical prostatectomy to culture and study in the laboratory.
Conditions
Interventions
- PROCEDURE
-
Robotic Radical Prostatectomy
Routine NHS Radical Prostatectomy
Sponsors & Collaborators
-
Imperial College Healthcare NHS Trust
collaborator OTHER -
Experimental Cancer Medicine Centres
collaborator OTHER -
Imperial College London
lead OTHER
Principal Investigators
-
Charlotte Bevan, PhD · Imperial College London
-
Mathias Winkler, FRCS · Imperial College Healthcare NHS Trust
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2023-10-01
- Completion
- 2024-10-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%
NCT07115992 ·Status: RECRUITING ·Phase: NA
-
FACBC Outcomes for Post Prostatectomy
NCT01666808 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer
NCT02710721 ·Status: COMPLETED ·Phase: NA
-
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06756334 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study of Focal Cryoablation in Low-Risk Prostate Cancer
NCT00774436 ·Status: COMPLETED ·Phase: PHASE2
-
PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing
NCT06460454 ·Status: COMPLETED
-
Improving Energy Balance in Men With Prostate Cancer
NCT01886677 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Localized Prostate Cancer Treatments
NCT01492751 ·Status: ACTIVE_NOT_RECRUITING
-
Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model
NCT05587192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer
NCT02121600 ·Status: TERMINATED ·Phase: NA
-
12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer
NCT04724577 ·Status: UNKNOWN ·Phase: NA
-
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer
NCT05533515 ·Status: COMPLETED
-
Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer
NCT02968784 ·Status: TERMINATED ·Phase: NA
-
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer
NCT06585007 ·Status: RECRUITING ·Phase: PHASE3
-
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
NCT04067713 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
NCT06700057 ·Status: RECRUITING
-
The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy
NCT05109910 ·Status: RECRUITING ·Phase: NA
-
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy
NCT05896371 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
NCT01961713 ·Status: RECRUITING
-
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
NCT02730338 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome
NCT06917781 ·Status: RECRUITING ·Phase: NA
-
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
NCT05106699 ·Status: RECRUITING ·Phase: NA
-
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
NCT05570994 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
All-in-One Prostate Cancer Staging with MRI
NCT06071195 ·Status: RECRUITING